Oral Speakers
Perry Howard, PhD
University of Victoria, Victoria (Canada)
Understanding the role of ARS2 in RNA processing: from the nucleus to the cytoplasm
Maria L. Spletter, PhD
University of Missouri Kansas City, Kansas City (USA)
Erzsebet Fekete, PhD
University of Debrecen, Debrecen (Hungary)
Spliceosomal twin introns (“stwintrons”) in fungi: structure, distribution and evolution
Tongsen Zheng, PhD
Director of GI Medical Oncology Department & Phase I Trials Center Harbin, Heilongjiang (China)
pmSTING: A novel STING isoform embedded within the cytomembrane sensing extracellular cGAMP directly
Katrina Lappin, PhD
Queen’s University Belfast, Belfast (Northern Ireland)
The relationship between spliceosome mutations and immune activation in cance
Michela A. Denti, PhD
Department of Cellular, Computational and Integrative Biology (CIBIO) University of Trento, Trento (Italy)
Exon Skipping Through Chimeric Antisense >U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect
Yunlong Liu, PhD
Indiana University School of Medicine, Indianopolis (USA)
Roles of Alternative Splicing in Substance Use Disorder
Sabine Müller, PhD
Universität Greifswald, Institut für Biochemie, Greifswald (Germany)
RNA splicing by small engineered ribozymes
Lisa Müller, PhD
Institute of Virology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf (Germany)
Modeling intrinsic splice site strength: Effects of SREs on HIV gene expression
Martin Schroeder, PhD
Department of Biosciences Durham University, Durham (UK)
RNA splicing in the unfolded protein response
Ya-Xiong Tao, PhD
Department of Anatomy, Physiology & Pharmacology, Auburn University, Auburn (USA)
Splicing variants of melanocortin-2 receptor accessory proteins
Xianquan Zhan, PhD
Shandong First Medical University, Shandong (China)
Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine
Liliana Florea, PhD
Johns Hopkins School of Medicine, Baltimore (USA)
Methods for differential splicing detection
Maria Costa, PhD
Institute for Integrative Biology of the Cell ( I2BC) – University Paris-Saclay, CEA, CNRS, Gif-sur-Yvette (France)
Group II Intron Splicing and its Implications for Spliceosomal Splicing
Franck Dequiedt, PhD
University of Liege, Liège (Belgium)
Perturbations of the cellular splicing landscape by oncogenic transcription factors
Pablo Vivas-Mejia, PhD
University of Puerto Rico Medical Sciences, San Juan (Porto Rico)
Increased expression of the RBPMS splice variants inhibit cell proliferation in ovarian cancer cells
Jianfei Hu, PhD
Head of Genomics Analysis Core Vaccine Research Center National Institutes of Health, Maryland (USA)
Stochastic Principles Governing Alternative Splicing of RNA
Christoph Winkler, PhD
Department of Biological Sciences National University of Singapore (Singapore)
Srsf6b-induced splicing defects contribute to selective motor neuron vulnerability in a zebrafish model for Spinal Muscular Atrophy